28 years designing and implementing sustainable solutions to patient access challenges.
Discover the people and purpose behind our work to expand access.
Explore the patient-centered approach and evidence behind our work.
Join our team and help shape the future of access.
A network of experienced access specialists around the world.
Real-world insights and best practices to inform more sustainable access to healthcare strategies.
View All
Learnings from access programs and initiatives around the world.
Peer-reviewed research advancing healthcare access.
Perspectives, ideas, and news shaping the future of healthcare access.
Building sustainable access to healthcare solutions for every step of the patient journey.
Learn More
Overcoming complex self-pay market barriers with sustainable access strategies.
Personalized support to help patients complete their course of treatment.
Helping patients get the right diagnosis sooner.
Making care and treatment more convenient for patients.
Removing treatment affordability barriers so patients can access the treatment they need.
Technology that connects, simplifies, and continuously improves the patient journey.
Real-world data for better patient access
Explore peer-reviewed publications on Axios-managed access programs and tools, contributing real-world evidence and insights to the evolving body of knowledge on healthcare access.
Publication
Journal of Clinical Oncology
Filter
This qualitative study interviewed 40 stakeholders, including doctors, hospital administrators, government officials, and community members, across two Brazilian states to understand how dengue outbreaks ripple through healthcare systems, households, schools, and local economies. Outbreaks strained
This study surveyed the managers of 29 HPV vaccination programs across 19 countries to capture the practical obstacles and solutions encountered while rolling out vaccination campaigns for adolescent girls. Misinformation about the vaccine's safety, difficulty tracking girls for follow-up doses, and
This study tracked 64 HIV prevention programs across 25 sub-Saharan African countries over more than a decade to see how well they succeeded in getting the HIV-prevention drug nevirapine to pregnant women who needed it. Coverage improved significantly over time, especially after 2006, and programs r
This study analyzed 21 HPV vaccination programs across 14 low- and middle-income countries, all run through a vaccine donation program, to identify which delivery approaches got the most girls fully vaccinated. Programs run out of schools or health clinics, and those managed by NGOs rather than gove
This study surveyed physicians, hospital administrators, and health ministry officials in 39 developing countries to understand how the Glivec International Patient Assistance Program (GIPAP), which provides free leukemia medication, affected care beyond just the drug itself. Physicians reported maj
This study analyzed nearly 5,000 patients across 47 institutions in 44 countries enrolled in the same leukemia drug access program (GIPAP) to identify what institutional characteristics predict how many patients get enrolled and how well they do afterward. Having a hematologist or oncologist on staf
This business school case study examines a real pricing dilemma: a life-prolonging cancer drug priced at $1,000/month was unaffordable for most patients in China, and the case asks students to work through what pricing strategy a health access consultancy should recommend to the drug's manufacturer.
This study surveyed the managers of 99 institutions across 34 countries that participated in an 11-year HIV drug donation program aimed at preventing mothers from transmitting HIV to their babies. The large majority of program managers reported that the donation program expanded services, reduced st
This study surveyed nearly 600 private pharmacies and drug shops in Ghana, Kenya, Nigeria, Tanzania, and Uganda to see how a Global Fund program (AMFm) affected the price and availability of quality malaria medicine in the private sector, where most patients in Africa actually seek treatment. Subsid